EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CD155/PVR determines acute myeloid leukemia targeting by Delta One T cells

Sofia Mensurado iD, Carolina Condeço iD, Diego Sánchez-Martínez iD, Sara Shirley iD, Rui M L Coelho iD, Néstor Tirado iD, Meritxell Vinyoles iD, Rafael Blanco-Domínguez iD, Leandro Barros iD, Beatriz Galvão iD, Noélia Custódio iD, Maria Gomes da Silva iD und 2 weitere

Blood · 2024

DOI: 10.1182/blood.2023022992 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood, 2024. Verfasst von Sofia Mensurado und 13 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. Hauptthemen laut MEDLINE: Cytotoxicity, Immunologic, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Relapsed or refractory acute myeloid leukemia (AML) remains a major therapeutic challenge. We have recently developed a Vδ1+ γδ T cell–based product for adoptive immunotherapy, named Delta One T (DOT) cells, and demonstrated their cytolytic capacity to eliminate AML cell lines and primary blasts in vitro and in vivo. However, the molecular mechanisms responsible for the broad DOT-cell recognition of AML cells remain poorly understood. Here, we dissected the role of natural killer (NK) cell receptor ligands in AML cell recognition by DOT cells. Screening of multiple AML cell lines highlighted a strong upregulation of the DNAM-1 ligands, CD155/pulmonary vascular resistance (PVR), CD112/nectin-2, as well as the NKp30 ligand, B7-H6, in contrast with NKG2D ligands. CRISPR-mediated ablation revealed key nonredundant and synergistic contributions of PVR and B7-H6 but not nectin-2 to DOT-cell targeting of AML cells. We further demonstrate that PVR and B7-H6 are critical for the formation of robust immunological synapses between AML and DOT cells. Importantly, PVR but not B7-H6 expression in primary AML samples predicted their elimination by DOT cells. These data provide new mechanistic insight into tumor targeting by DOT cells and suggest that assessing PVR expression levels may be highly relevant to DOT cell–based clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytotoxicity, ImmunologicLeukemia, Myeloid, AcuteHumansKiller Cells, NaturalT-LymphocytesCell Line

Autor:innen und Institutionen

  • Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
  • Josep Carreras Leukaemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.
  • Red Española de Terapias Avanzadas, Instituto de Salud Carlos III, Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RD21/0017/0029), Madrid, Spain.
  • Aragon Health Research Institute, Centro de Investigación Biomédica en Red en Enfermedades Infecciosas, Instituto de Salud Carlos III, Zaragoza, Spain.
  • Aragon I+D Foundation, Zaragoza, Spain.
  • Instituto Português de Oncologia Francisco Gentil, Lisbon, Portugal.

ORCID-Profile: Sofia Mensurado, Carolina Condeço, Diego Sánchez-Martínez, Sara Shirley, Rui M L Coelho, Néstor Tirado, Meritxell Vinyoles, Rafael Blanco-Domínguez, Leandro Barros, Beatriz Galvão, Noélia Custódio, Maria Gomes da Silva, Pablo Menéndez, Bruno Silva-Santos

Zitieren

APA

Mensurado, S., Condeço, C., Sánchez-Martínez, D., Shirley, S., Coelho, R. M. L., Tirado, N., Vinyoles, M., Blanco-Domínguez, R., Barros, L., Galvão, B., Custódio, N., Gomes da Silva, M., Menéndez, P., & Silva-Santos, B. (2024). CD155/PVR determines acute myeloid leukemia targeting by Delta One T cells. Blood. https://doi.org/10.1182/blood.2023022992

Vancouver

Mensurado S, Condeço C, Sánchez-Martínez D, Shirley S, Coelho RML, Tirado N, et al. CD155/PVR determines acute myeloid leukemia targeting by Delta One T cells. Blood. 2024. doi:10.1182/blood.2023022992

BibTeX
@article{Mensurado2024,
  author = {Mensurado, Sofia and Condeço, Carolina and Sánchez-Martínez, Diego and Shirley, Sara and Coelho, Rui M L and Tirado, Néstor and Vinyoles, Meritxell and Blanco-Domínguez, Rafael and Barros, Leandro and Galvão, Beatriz and Custódio, Noélia and Gomes da Silva, Maria and Menéndez, Pablo and Silva-Santos, Bruno},
  title = {CD155/PVR determines acute myeloid leukemia targeting by Delta One T cells},
  journal = {Blood},
  year = {2024},
  doi = {10.1182/blood.2023022992}
}
Kostenlos starten →